Are There Resources for AAT Deficiency?

Watch a demo video on how to screen for alpha₁-antitrypsin (AAT) deficiency with AlphaID™, the fast, free, and accurate cheek swab that is provided compliments of Grifols and may not be billed to patients or their insurers.

Watch respiratory therapy director Gretchen Kolhoff explain the urgency of screening for alpha-1 and the fact that only a genetic test can provide a differential diagnosis.

Watch alpha-1 experts describe the easy screening process for AAT deficiency and the benefits of diagnosing alpha-1 in its early stages.

Watch an expert panel discuss why AAT deficiency remains highly underdiagnosed and why they advocate for alpha-1 screening.

Watch experts review the genetic origins of alpha-1 and the criteria used to determine whether a patient should be screened for AAT deficiency.

Watch an expert panel describe the emotional impact of alpha-1 screening on patients and how a diagnosis often motivates those patients to be more proactive about their health.

Watch this video to learn how alpha-1 is the #1 known genetic risk factor for COPD. Alpha-1 may be a contributing cause in up to 480,000 cases of COPD in the United States.

Watch this video to learn why genetic screening for alpha-1 in all patients with COPD or treatment-resistant asthma is recommended, regardless of age, smoking history, or FEV₁.

Watch to learn why screening for alpha-1 is important. Approximately 90% of patients with alpha-1, also known as genetic COPD, are estimated to be undiagnosed.

Watch Corinne Young, FNP-C, FCCP, and her patient Carol as they talk about Carol’s journey to diagnosis with alpha-1.

Watch Daryl’s story. Initially misdiagnosed with asthma, he is an ultra-distance cyclist living with alpha-1 who now champions genetic screening for patients and their families.

Watch Carla’s story. Carla had breathing problems her whole life. Then a chance encounter with a nurse practitioner changed Carla’s life when she was tested for alpha-1.

Watch Doreen’s story. It took eight years of being incorrectly treated for bronchitis and asthma before Doreen received her alpha-1 diagnosis. Twenty years later, she continues to advocate for screening of alpha-1.